ADAM9 was observed to be highly expressed in CHOL, whereas ADAM33 had a significantly lower expression in pan-cancers, especially in BLCA and UCEC (Figure 1C). The gene discussed is ADAM33; the disease is bladder transitional cell carcinoma.